Literature DB >> 9888593

Differential expression of an orphan receptor COUP-TFI and corepressors in adrenal tumors.

H Shibata1, T Ando, T Suzuki, I Kurihara, K Hayashi, M Hayashi, I Saito, H Kawabe, M Tsujioka, M Mural, T Saruta.   

Abstract

Recently, it has been shown that CYP17 gene transcription is activated by SF-1 (Steroidogenic Factor-1) binding to a cyclic AMP-responsive sequence within the promoter region of the gene, whereas it is inhibited by COUP-TF (Chicken Ovalbumin Upstream Promoter-Transcription Factor) binding to the sequence. We have shown that transcriptional repression by COUP-TFI is mediated by corepressors, N-CoR (nuclear receptor corepressor) and SMRT (silencing mediator for retinoid and thyroid hormone-receptor). Therefore, we compared the expression of COUP-TFI, N-CoR and SMRT in non-hyperfunctioning adrenocortical adenomas and normal adrenal glands. We found significantly higher expression of COUP-TFI mRNA in non-hyperfunctioning adenomas (n=5, 227+/-18%) than in normal adrenals (n=5, 96+/-4%). Interestingly, the pattern of N-CoR and SMRT expression was different compared with COUP-TFI expression. These data suggest that COUP-TFI, N-CoR, and SMRT may play a differential role in steroid biosynthesis of non-hyperfunctioning adenomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9888593     DOI: 10.3109/07435809809032703

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  2 in total

1.  Coactivation of SF-1-mediated transcription of steroidogenic enzymes by Ubc9 and PIAS1.

Authors:  Noriko Suda; Hirotaka Shibata; Isao Kurihara; Yayoi Ikeda; Sakiko Kobayashi; Kenichi Yokota; Ayano Murai-Takeda; Ken Nakagawa; Mototsugu Oya; Masaru Murai; William E Rainey; Takao Saruta; Hiroshi Itoh
Journal:  Endocrinology       Date:  2011-04-05       Impact factor: 4.736

2.  COUP-TFII regulates metastasis of colorectal adenocarcinoma cells by modulating Snail1.

Authors:  Y Bao; D Gu; W Feng; X Sun; X Wang; X Zhang; Q Shi; G Cui; H Yu; C Tang; A Deng
Journal:  Br J Cancer       Date:  2014-07-17       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.